XM
EVFM

XTX Markets’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

XTX Markets’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$137K Buy
+3,790
New +$137K 0.28% 157

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

XTX Markets's EVFM Position: Q4 2020 in Review

XTX Markets opened a new position in Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2020: 3,790 shares worth $137K. The stake represents 0.28% of the portfolio and ranks #157 among its holdings.

93 funds tracked by Wall St. Rank hold EVFM as of Q4 2020.

  • XTX Markets held 3,790 shares of Evofem Biosciences, Inc. Common Stock worth $137K as of Q4 2020.
  • Evofem Biosciences, Inc. Common Stock was a new XTX Markets position in Q4 2020.
  • Evofem Biosciences, Inc. Common Stock made up 0.28% of XTX Markets's portfolio in Q4 2020, its #157 holding.
  • 93 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.